These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 354136)

  • 41. Prolonged survival of renal allografts in tissue typed beagles by treatment with ALS and donor bone marrow.
    Jeekel J; Obertop H; Westbroek DL; Vriesendorp HM
    Transplantation; 1976 Nov; 22(5):534-7. PubMed ID: 793111
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays.
    Gloor JM; Moore SB; Schneider BA; Degoey SR; Stegall MD
    Transplantation; 2007 Jul; 84(2):258-64. PubMed ID: 17667819
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of cytotoxic (sensitization) and enhancing (prolonged survival) responses by injection of lymphoid cells in ALS-treated mice.
    Wood ML; Monaco AP
    Transplant Proc; 1979 Jun; 11(2):1456-7. PubMed ID: 382539
    [No Abstract]   [Full Text] [Related]  

  • 44. Disappearance of anti-HLA antibodies in highly sensitized patients treated with erythropoietin.
    Mourad G; Cristol JP; Chong G; Lorho R; Argiles A; Seignalet J; Mion C
    Transplant Proc; 1992 Dec; 24(6):2512-3. PubMed ID: 1465849
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical relevance of pretransplant flow cytometric crossmatches with T and B lymphocytes in kidney transplantation.
    Berteli AJ; Daniel V; Pomer S; Opelz G
    Transplant Proc; 1990 Aug; 22(4):1895-6. PubMed ID: 2389477
    [No Abstract]   [Full Text] [Related]  

  • 46. No synergy between ATG induction and costimulation blockade induced kidney allograft survival in rhesus monkeys.
    Haanstra KG; Sick EA; Ringers J; Wubben JA; Kuhn EM; 't Hart BA; Boon L; Jonker M
    Transplantation; 2006 Nov; 82(9):1194-201. PubMed ID: 17102771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical immunosuppression with antilymphocyte globulin.
    Stiller CR
    Can Med Assoc J; 1976 Dec; 115(12):1190-1. PubMed ID: 793703
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of captopril treatment on allograft survival and induction of unresponsiveness in heart-transplanted, ATG-treated rats.
    Olausson M; Mjörnstedt L; Wramner L; Herlitz H
    Nephrol Dial Transplant; 1992; 7(11):1130-2. PubMed ID: 1336141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of steroid-resistant rejections with ATG and/or plasma filtration improves graft survival rates after cadaveric kidney transplantation.
    Fassbinder W; Bechstein PB; Stutte HJ; Scheuermann EH; Hanke P; Knöner M; Dathe G; Jonas D; Schoeppe W
    Neth J Med; 1985; 28(6):265-7. PubMed ID: 3892329
    [No Abstract]   [Full Text] [Related]  

  • 50. Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine.
    Knight RJ; Kerman RH; Podder H; Katz SM; Van Buren CT; Kahan BD
    Transplant Proc; 2005 Mar; 37(2):1280-2. PubMed ID: 15848695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The positive B-cell cross-match: a marker of active enhancement?
    d'Apice AJ; Tait BD
    Transplant Proc; 1979 Mar; 11(1):954-7. PubMed ID: 377728
    [No Abstract]   [Full Text] [Related]  

  • 52. Immunologic correlates of human renal allograft survival.
    Etheredge EE; Sicard GA; Anderson CB
    Transplant Proc; 1979 Mar; 11(1):354-9. PubMed ID: 377655
    [No Abstract]   [Full Text] [Related]  

  • 53. Influence of race, PRA level, and gender on the incidence of a positive donor-specific preliminary T cell crossmatch.
    Bryan CF; Aeder MI; Helling TS; Luger AM; Nelson PW; Pierce GE; Shield CF; Thomas A
    Transplant Proc; 1992 Dec; 24(6):2517-8. PubMed ID: 1465851
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunologic monitoring of antithymocyte globulin treatment for acute allograft rejection.
    Delmonico FL; Nelson PW; Colvin RB; Cosimi AB
    Transplant Proc; 1984 Dec; 16(6):1492-3. PubMed ID: 6390852
    [No Abstract]   [Full Text] [Related]  

  • 55. [Immunosuppression by means of antilymphocyte serums in humans].
    Revillard JP
    Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of alloantibodies on corneal allograft survival.
    Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Requirement for DR sharing in stable kidney allograft tolerance induced by donor bone marrow in rhesus monkeys.
    Thomas J; Kasten-Jolly J; Verbanac K; Smith JP; Carver M; Gross U; Rebellato L; Thomas F; Haisch C
    Transplant Proc; 1995 Feb; 27(1):166-8. PubMed ID: 7878957
    [No Abstract]   [Full Text] [Related]  

  • 58. In vitro immunoresponsiveness in recipients of cadaveric renal allografts during ATG therapy.
    Grosse-Wilde H; Jakubowski HD; Eigler FW; Kuwert EK
    Proc Eur Dial Transplant Assoc; 1981; 18():481-5. PubMed ID: 7036170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Use of delayed cyclosporin A in after administration of anti-lymphocyte serum in kidney transplantation].
    Hourmant M; Soulillou JP
    Biomed Pharmacother; 1987; 41(5):247-9. PubMed ID: 3311191
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A prospective study of prophylactic ATG versus cyclosporine in regrafted and highly sensitized renal allograft recipients.
    Pearson RC; Johnson RW; Bakran A; Dyer P; Martin S; O'Donoghue D; Scott PD
    Transplantation; 1990 Dec; 50(6):1061-3. PubMed ID: 2256151
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.